Home - The Dermatology Digest

Advertisement

Battle of the PsO Pills: Investigational Icotrokinra Bests Deucravacitinib (Sotyktu, BMS) in Phase 3 Trials

September 18, 2025

AD Pipeline Watch: Rezpegaldesleukin Hits Primary and Key Secondary Endpoints in REZOLVE-AD Phase 2b Study

September 18, 2025

Hot Drop Alert: Cetaphil’s New Skin Activator Hydrating & Firming Line Launches in Partnership With Actress Mariska Hargitay

September 18, 2025

EADV 2025 News: Delgocitinib Cream (Anzupgo, LEO Pharma) Performs Well in Adolescents With Moderate-to-Severe CHE

September 18, 2025

Tildrakizumab (Ilumetri, Almirall) Shows Sustained Improvements in Skin and Quality of Life in PsO Patients; Study Uses WHO 5 Well-Being Index as Primary Endpoint

September 18, 2025

EADV 2025 News: New Brivekimig Data Supports Targeting TNF and OX40L in HS

September 17, 2025

Advertisement

Advertisement

Latest Issue

Latest Supplements

Upcoming Conferences

Advertisement

Advertisement

Digital Edition Archive